Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Angioplasty Stories

2013-08-21 16:25:36

Online Submission Open for SIR's Annual Scientific Meeting March 22-27, 2014, in San Diego FAIRFAX, Va., Aug. 21, 2013 /PRNewswire-USNewswire/ -- Scientific abstracts covering all areas of vascular and nonvascular interventional radiology are being accepted for the Society of Interventional Radiology's 39th Annual Scientific Meeting, which will be held March 22-27, 2014, in San Diego, Calif. The deadline for abstract submission is Oct. 8. (Logo:...

2013-08-16 12:24:43

Bluhm Cardiovascular Institute enrolls first patient in ABSORB III trial studying "disappearing" heart device CHICAGO, Aug. 16, 2013 /PRNewswire-USNewswire/ -- Northwestern's Bluhm Cardiovascular Institute recently enrolled its first subject in ABSORB III, a clinical trial to study a "disappearing" heart device for the treatment of coronary artery disease (CAD). The investigational device, called the Absorb(TM) Bioresorbable Vascular Scaffold (BVS), made by healthcare company Abbott,...

2013-08-15 11:57:15

No evidence that impaired blood flow or blockage in the veins of the neck or head is involved in MS There is no evidence that impaired blood flow or blockage in the veins of the neck or head is involved in multiple sclerosis, says a McMaster University study. The research, published online by PLOS ONE today, found no evidence of abnormalities in the internal jugular or vertebral veins or in the deep cerebral veins of any of 100 patients with multiple sclerosis (MS) compared with 100...

2013-07-29 23:03:54

One of a Select Number of U.S. Centers Testing a "disappearing" Device That’s Absorbed by the Body Royal Oak, MI (PRWEB) July 29, 2013 Beaumont Health System has joined a multicenter, international research study of a new temporary heart device that helps keep an artery open following angioplasty, then is broken down and absorbed by the body. The research will compare the effectiveness of the new “disappearing” device, the AbsorbTM Bioresorbable Vascular Scaffold made by...

2013-07-18 08:29:30

More Mature Markets in Western Europe Will See Marginal Declines, According to Millennium Research Group TORONTO, July 18, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, markets for interventional cardiology (IC) devices have reached maturation in Belgium, Sweden, Switzerland and the Netherlands, while Eastern European markets will continue to see growth. Procedure volume growth will be slight in...

2013-07-12 08:23:50

Device Facilitates Delivery of Interventional Devices in Complex PCI Procedures NATICK, Mass., July 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla(TM) Guide Extension Catheter and has launched the device in the U.S. and Europe. The Guidezilla device is designed to make complex percutaneous coronary intervention (PCI) procedures easier by more efficiently...

2013-07-10 12:27:24

-- Enhanced Deliverability with New Stent Delivery System ABBOTT PARK, Ill., July 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved the XIENCE Xpedition(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD), the most common form of heart disease.(i )XIENCE Xpedition is supported by the robust clinical evidence of the XIENCE family of drug eluting stents...

2013-07-10 10:21:08

Emmanouil S. Brilakis, M.D., Ph.D., of the VA North Texas Health Care System and University of Texas Southwestern Medical Center at Dallas, and colleagues conducted a review of medical literature regarding optimal medical therapy after percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries). The researchers identified 91 studies for inclusion in the review. "Percutaneous coronary intervention is commonly...

2013-06-27 23:18:21

High growth in smaller segments of the European interventional cardiology market contributes to continued increase and development of the total market. Vancouver, BC (PRWEB) June 27, 2013 Heart disease is a major cause of death and hospitalization in several European countries, as observed in a 2012 OECD (Organisation for Economic Co-Operation and Development) study. While previous methods for treating obstructed coronary arteries involved open-chest surgery, this is no longer the case...

2013-06-20 12:30:21

Hospital using three-dimensional technology to scan brain and neck to prevent stroke TAMPA, Fla., June 20, 2013 /PRNewswire-USNewswire/ -- St. Joseph's Hospital in Tampa is the only hospital in the southeast United States using Non-invasive Optimal Vessel Analysis (NOVA) to quantify the volume of blood flow through tiny blood vessels in the brain using three dimensional imaging. The first of its kind, NOVA provides doctors with precise identification of each vessel for blood flow...


Latest Angioplasty Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »